SMTL ID : 2fye.1

Mutant Human Cathepsin S with irreversible inhibitor CRA-14013

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.20 Å

Oligo State

monomer

Ligands

1 x BCQ: N-[(1R)-1-[({[(5S)-3,5-DIMETHYL-2,5-DIHYDROISOXAZOL-4-YL]METHYL}SULFONYL)METHYL]-2-OXO-2-({(1S)-3-PHENYL-1-[2-(PHENYLSULFONYL)ETHYL]PROPYL}AMINO)ETHYL]MORPHOLINE-4-CARBOXAMIDE(Covalent)

BCQ.1: 21 residues within 4Å: Chain A: Q.19, G.23, C.25, W.26, G.62, K.64, C.66, N.67, G.68, G.69, F.70, M.71, G.137, A.140, F.146, V.162, N.163, H.164, G.165, W.186, F.211 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:F.70, A:F.146, A:W.186 Hydrogen bonds: A:G.69, A:G.69, A:N.163

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Somoza, J.R., Mutant Human Cathepsin S with irreversible inhibitor CRA-14013. To be Published

Release Date

2006-08-08

Peptides

cathepsin S preproprotein: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

cathepsin S preproprotein